Skip to main content
Clinical Trials/NCT00773565
NCT00773565CompletedNot Applicable

Identification of Novel Targets for Regulation of Adipose Tissue Mass

Gottfried Rudofsky2 sites in 1 country62 target enrollmentStarted: October 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
62
Locations
2
Primary Endpoint
number of adipocytes and preadipocytes under weight loss

Study Overview

Brief Summary

The aim of this study is to understand the metabolic changes occurring in fat tissue both during controlled weight loss that lead to the improvement of type 2 diabetes and other obesity associated metabolic disorders. The novelty of the study is the analysis of preadipocytes, a poorly characterized subfraction of the adipose tissue, which provides adipocyte precursors and thereby strongly influences adipose tissue mass changes. Knowledge of pathways involved in controlling adipose tissue composition will help to design novel intervention strategies for the treatment of obesity associated metabolic disorders such as type 2 diabetes.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Participants of the OPTIFAST52 program
  • BMI > 30 kg/m2

Exclusion Criteria

  • Rejection of informed consent by the participant

Outcomes

Primary Outcomes

number of adipocytes and preadipocytes under weight loss

Time Frame: three years

Secondary Outcomes

  • metabolic function of adipocytes and preadipocytes under weight loss(three years)

Investigators

Sponsor
Gottfried Rudofsky
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Gottfried Rudofsky

Oberarzt

Heidelberg University

Study Sites (2)

Loading locations...

Similar Trials